Browse Title Index
| Issue | Title | |
| Vol 1, No 1 (2010) | Treatment of elderly patients with acute lymphoblastic leukemia | Abstract PDF (Polish) |
| Sebastian Giebel | ||
| Vol 4, No 2 (2013) | Treatment of elderly patients with Hodgkin lymphoma | Abstract PDF (Polish) HTML (Polish) |
| Olga Dobrzyńska, Tomasz Wróbel | ||
| Vol 4, No 3 (2013) | Treatment of patients with aplastic anemia | Abstract PDF (Polish) HTML (Polish) |
| Kazimierz Hałaburda, Agnieszka Tomaszewska | ||
| Vol 9, Supp. A (2018) | Treatment of patients with chronic myelogenous leukemia with tyrosine kinase inhibitors — skirmishes with side effects of medications | Abstract PDF (Polish) |
| Justyna Gil | ||
| Vol 1, No 1 (2010) | Treatment of patients with diffuse large B-cell lymphoma | Abstract PDF (Polish) |
| Anne-Sophie Michallet, Bertrand Coiffier | ||
| Vol 1, No 4 (2010) | Treatment of patients with lymphoma and coexisting infection with HCV, HBV or HIV | Abstract PDF (Polish) |
| Ewa Kalinka-Warzocha | ||
| Vol 2, No 1 (2011) | Treatment of patients with Philadelphia positive acute lymphoblastic leukemia | Abstract PDF (Polish) |
| Sebastian Giebel, Beata Piątkowska-Jakubas, Maria Adamczyk-Cioch, Anna Czyż, Janusz Hałka, Małgorzata Krawczyk-Kuliś, Ewa Lech-Marańda, Jarosław Piszcz, Beata Stella-Hołowiecka, Anna Polakiewicz, Jerzy Hołowiecki | ||
| Vol 11, No 1 (2020) | Treatment options for relapsed/refractory multiple myeloma in Poland within the reach of the Ministry of Health drug program in relation to European Society for Medical Oncology recommendations | Abstract PDF (Polish) |
| Grzegorz Charliński | ||
| Vol 11, Supp. B (2020) | Treatment-free remission in clinical practice: nilotinib treatment discontinuation in six chronic myelogenous leukemia patients — single-center experience | Abstract PDF (Polish) |
| Joanna Niesiobędzka-Krężel | ||
| Vol 12, Supp. C (2021) | Treatment-resistant aggressive systemic mastocytosis | Abstract PDF (Polish) |
| Karolina Chromik, Paulina Lis, Patryk Węglarz, Grzegorz Helbig | ||
| Vol 1, No 3 (2010) | Tyrosine kinase inhibitors-induced myelosuppression - case report | Abstract PDF (Polish) |
| Małgorzata Całbecka | ||
| Vol 4, No 1 (2013) | Uncontrolled postoperative bleeding in woman with pemphigus and undiagnosed acquired haemophilia A | Abstract PDF (Polish) |
| Magdalena Górska-Kosicka, Piotr Paluszkiewicz, Dorota Krasowska, Anna Dmoszyńska, Jerzy Windyga | ||
| Vol 7, No 1 (2016) | Unusual localisation of amyloid deposits in plasma cell myeloma | Abstract PDF (Polish) HTML (Polish) |
| Jacek Szymańczyk, Ryszard Pogłód, Maria Kraj, Agnieszka Michalska, Monika Prochorec-Sobieszek, Janusz Szymańczyk | ||
| Vol 1, No 3 (2010) | Updated concepts in the treatment of chronic myeloid leukemia in 2010 | Abstract PDF (Polish) |
| Andrzej Hellmann | ||
| Vol 10, No 2 (2019) | Use of next generation sequencing for clonal heterogeneity and minimal residual disease assessment in plasma cell myeloma patients | Abstract PDF (Polish) |
| Iwona Solarska, Bartosz Puła, Agnieszka Krzywdzińska, Krzysztof Jamroziak | ||
| Vol 12, Supp. B (2021) | Variable clinical course of immune thrombocytopenia | Abstract PDF (Polish) |
| Joanna Zdziarska | ||
| Vol 11, No 2 (2020) | Venetoclax monotherapy before second allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia | Abstract PDF (Polish) |
| Bartosz Puła, Joanna Mańko, Monika Pępek, Tomasz Stokłosa, Kazimierz Hałaburda, Ewa Lech-Marańda, Iwona Hus | ||
| Vol 7, No 3 (2016) | Venous thromboembolism — practical aspects of treatment | Abstract PDF (Polish) |
| Krystyna Zawilska, Klaudia Zawilska | ||
| Vol 13, No 3-4 (2022) | Waldenström macroglobulinemia: diagnosis and treatment | Abstract PDF |
| Krzysztof Giannopoulos | ||
| Vol 11, No 1 (2020) | Will the use of autologous blood derivatives be the gold standard in various medicine specialties in the 21st century? | Abstract PDF (Polish) |
| Jacek Nowak, Marcin Adamiec, Bartłomiej Iwańczyk, Maciej Czerniuk | ||
| Vol 10, Supp. A (2019) | Wpływ azacytydyny na poprawę jakości życia u pacjentów w podeszłym wieku z zespołami mielodysplastycznymi z grupy pośredniego-2 ryzyka | Abstract PDF (Polish) |
| Judyta Strzała, Wojciech Baran | ||
| Vol 12, Supp. A (2021) | Wydłużenie przeżycia u chorej na przewlekłą białaczkę szpikową w fazie kryzy blastycznej leczonej ponatynibem | Abstract PDF (Polish) |
| Elżbieta Szczepanek, Beata Piątkowska-Jakubas, Tomasz Sacha | ||
| Vol 11, No 4 (2020) | Young CLL patient with 17p deletion and relapse after immunochemotherapy treated with venetoclax — case report and literature review | Abstract PDF (Polish) |
| Anna Dąbrowska-Iwanicka, Katarzyna Błachnio, Renata Woroniecka, Grzegorz Rymkiewicz, Jan Walewski | ||
| Vol 12, Supp. A (2021) | Zastosowanie ponatynibu u pacjenta po wcześniejszym niepowodzeniu leczenia imatynibem i toksyczności dazatynibu | Abstract PDF (Polish) |
| Michał Janowski, Edyta Paczkowska | ||
| Vol 9, No 3 (2018) | Zdaniem (byłego) konsultanta | Abstract PDF (Polish) |
| Wiesław Wiktor Jędrzejczak | ||
| 501 - 525 of 543 Items | << < 16 17 18 19 20 21 22 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
